Global Hemophilia Therapeutics Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application
SKU ID : QYR-16374893 | Publishing Date : 08-Sep-2020 | No. of pages : 119
Detailed TOC of Global Hemophilia Therapeutics Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application
1 Market Overview of Hemophilia Therapeutics1.1 Hemophilia Therapeutics Market Overview
1.1.1 Hemophilia Therapeutics Product Scope
1.1.2 Market Status and Outlook
1.2 Global Hemophilia Therapeutics Market Size Overview by Region 2015 VS 2020 VS 2026
1.3 Global Hemophilia Therapeutics Market Size by Region (2015-2026)
1.4 Global Hemophilia Therapeutics Historic Market Size by Region (2015-2020)
1.5 Global Hemophilia Therapeutics Market Size Forecast by Region (2021-2026)
1.6 Key Regions, Hemophilia Therapeutics Market Size YoY Growth (2015-2026)
1.6.1 North America Hemophilia Therapeutics Market Size YoY Growth (2015-2026)
1.6.2 Europe Hemophilia Therapeutics Market Size YoY Growth (2015-2026)
1.6.3 Asia-Pacific Hemophilia Therapeutics Market Size YoY Growth (2015-2026)
1.6.4 Latin America Hemophilia Therapeutics Market Size YoY Growth (2015-2026)
1.6.5 Middle East & Africa Hemophilia Therapeutics Market Size YoY Growth (2015-2026)
2 Hemophilia Therapeutics Market Overview by Type
2.1 Global Hemophilia Therapeutics Market Size by Type: 2015 VS 2020 VS 2026
2.2 Global Hemophilia Therapeutics Historic Market Size by Type (2015-2020)
2.3 Global Hemophilia Therapeutics Forecasted Market Size by Type (2021-2026)
2.4 hemophilia A
2.5 hemophilia B
2.6 hemophilia C
3 Hemophilia Therapeutics Market Overview by Application
3.1 Global Hemophilia Therapeutics Market Size by Application: 2015 VS 2020 VS 2026
3.2 Global Hemophilia Therapeutics Historic Market Size by Application (2015-2020)
3.3 Global Hemophilia Therapeutics Forecasted Market Size by Application (2021-2026)
3.4 Hospitals
3.5 Clinics
3.6 AmbulatorySurgicalCenters
4 Global Hemophilia Therapeutics Competition Analysis by Players
4.1 Global Hemophilia Therapeutics Market Size (Million US$) by Players (2015-2020)
4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemophilia Therapeutics as of 2019)
4.3 Date of Key Manufacturers Enter into Hemophilia Therapeutics Market
4.4 Global Top Players Hemophilia Therapeutics Headquarters and Area Served
4.5 Key Players Hemophilia Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Hemophilia Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Bayer AG
5.1.1 Bayer AG Profile
5.1.2 Bayer AG Main Business
5.1.3 Bayer AG Products, Services and Solutions
5.1.4 Bayer AG Revenue (US$ Million) & (2015-2020)
5.1.5 Bayer AG Recent Developments
5.2 Pfizer, Inc.
5.2.1 Pfizer, Inc. Profile
5.2.2 Pfizer, Inc. Main Business and Company’s Total Revenue
5.2.3 Pfizer, Inc. Products, Services and Solutions
5.2.4 Pfizer, Inc. Revenue (US$ Million) (2015-2020)
5.2.5 Pfizer, Inc. Recent Development and Reaction to Covid-19
5.3 Novo Nordisk A/S
5.5.1 Novo Nordisk A/S Profile
5.3.2 Novo Nordisk A/S Main Business
5.3.3 Novo Nordisk A/S Products, Services and Solutions
5.3.4 Novo Nordisk A/S Revenue (US$ Million) & (2015-2020)
5.3.5 Baxter International Inc. Recent Developments
5.4 Baxter International Inc.
5.4.1 Baxter International Inc. Profile
5.4.2 Baxter International Inc. Main Business
5.4.3 Baxter International Inc. Products, Services and Solutions
5.4.4 Baxter International Inc. Revenue (US$ Million) & (2015-2020)
5.4.5 Baxter International Inc. Recent Developments
5.5 Biogen Idec, Inc.
5.5.1 Biogen Idec, Inc. Profile
5.5.2 Biogen Idec, Inc. Main Business
5.5.3 Biogen Idec, Inc. Products, Services and Solutions
5.5.4 Biogen Idec, Inc. Revenue (US$ Million) & (2015-2020)
5.5.5 Biogen Idec, Inc. Recent Developments
5.6 Genetics Institute
5.6.1 Genetics Institute Profile
5.6.2 Genetics Institute Main Business
5.6.3 Genetics Institute Products, Services and Solutions
5.6.4 Genetics Institute Revenue (US$ Million) & (2015-2020)
5.6.5 Genetics Institute Recent Developments
5.7 Alpha Therapeutics Corporation
5.7.1 Alpha Therapeutics Corporation Profile
5.7.2 Alpha Therapeutics Corporation Main Business and Company’s Total Revenue
5.7.3 Alpha Therapeutics Corporation Products, Services and Solutions
5.7.4 Alpha Therapeutics Corporation Revenue (US$ Million) (2015-2020)
5.7.5 Alpha Therapeutics Corporation Recent Development and Reaction to Covid-19
5.8 Expression Therapeutics
5.8.1 Expression Therapeutics Profile
5.8.2 Expression Therapeutics Main Business
5.8.3 Expression Therapeutics Products, Services and Solutions
5.8.4 Expression Therapeutics Revenue (US$ Million) & (2015-2020)
5.8.5 Expression Therapeutics Recent Developments
5.9 Swedish Orphan Biovitrum AB.
5.9.1 Swedish Orphan Biovitrum AB. Profile
5.9.2 Swedish Orphan Biovitrum AB. Main Business
5.9.3 Swedish Orphan Biovitrum AB. Products, Services and Solutions
5.9.4 Swedish Orphan Biovitrum AB. Revenue (US$ Million) & (2015-2020)
5.9.5 Swedish Orphan Biovitrum AB. Recent Developments
6 North America
6.1 North America Hemophilia Therapeutics Market Size by Country
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Hemophilia Therapeutics Market Size by Country
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Hemophilia Therapeutics Market Size by Region
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Hemophilia Therapeutics Market Size by Country
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Hemophilia Therapeutics Market Size by Country
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Hemophilia Therapeutics Market Dynamics
11.1 Industry Trends
11.2 Market Drivers
11.3 Market Challenges
11.4 Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Figures, Tables and Charts Available in Global Hemophilia Therapeutics Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application
List of TablesTable 1. Global Market Hemophilia Therapeutics Market Size (US$ Million) Comparison by Region 2015 VS 2020 VS 2026
Table 2. Global Hemophilia Therapeutics Market Size by Region (2015-2020) (US$ Million)
Table 3. Global Hemophilia Therapeutics Market Size Share by Region (2015-2020)
Table 4. Global Hemophilia Therapeutics Forecasted Market Size by Region (2021-2026) (US$ Million)
Table 5. Global Hemophilia Therapeutics Forecasted Market Size Share by Region (2021-2026)
Table 6. Global Hemophilia Therapeutics Market Size (US$ Million) by Type: 2015 VS 2020 VS 2026
Table 7. Global Hemophilia Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 8. Global Hemophilia Therapeutics Revenue Market Share by Type (2015-2020)
Table 9. Global Hemophilia Therapeutics Forecasted Market Size by Type (2021-2026) (US$ Million)
Table 10. Global Hemophilia Therapeutics Revenue Market Share by Type (2021-2026)
Table 11. Global Hemophilia Therapeutics Market Size (US$ Million) by Application: 2015 VS 2020 VS 2026
Table 12. Global Hemophilia Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 13. Global Hemophilia Therapeutics Revenue Market Share by Application (2015-2020)
Table 14. Global Hemophilia Therapeutics Forecasted Market Size by Application (2021-2026) (US$ Million)
Table 15. Global Hemophilia Therapeutics Revenue Market Share by Application (2021-2026)
Table 16. Global Hemophilia Therapeutics Revenue (US$ Million) by Players (2015-2020)
Table 17. Global Hemophilia Therapeutics Revenue Market Share by Players (2015-2020)
Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemophilia Therapeutics as of 2019)
Table 19. Date of Key Manufacturers Enter into Hemophilia Therapeutics Market
Table 20. Global Hemophilia Therapeutics Top Players Headquarters and Area Served
Table 21. Hemophilia Therapeutics Product Solution and Service
Table 22. Global Hemophilia Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Bayer AG Basic Information List
Table 25. Bayer AG Description and Business Overview
Table 26. Bayer AG Hemophilia Therapeutics Products, Services and Solutions
Table 27. Revenue (Million US$) in Hemophilia Therapeutics Business of Bayer AG (2015-2020)
Table 28. Bayer AG Recent Developments
Table 29. Pfizer, Inc. Basic Information List
Table 30. Pfizer, Inc. Description and Business Overview
Table 31. Pfizer, Inc. Hemophilia Therapeutics Products, Services and Solutions
Table 32. Revenue (Million US$) in Hemophilia Therapeutics Business of Pfizer, Inc. (2015-2020)
Table 33. Pfizer, Inc. Recent Developments
Table 34. Novo Nordisk A/S Basic Information List
Table 35. Novo Nordisk A/S Description and Business Overview
Table 36. Novo Nordisk A/S Hemophilia Therapeutics Products, Services and Solutions
Table 37. Revenue (Million US$) in Hemophilia Therapeutics Business of Novo Nordisk A/S (2015-2020)
Table 38. Novo Nordisk A/S Recent Developments
Table 39. Baxter International Inc. Basic Information List
Table 40. Baxter International Inc. Description and Business Overview
Table 41. Baxter International Inc. Hemophilia Therapeutics Products, Services and Solutions
Table 42. Revenue (Million US$) in Hemophilia Therapeutics Business of Baxter International Inc. (2015-2020)
Table 43. Baxter International Inc. Recent Developments
Table 44. Biogen Idec, Inc. Basic Information List
Table 45. Biogen Idec, Inc. Description and Business Overview
Table 46. Biogen Idec, Inc. Hemophilia Therapeutics Products, Services and Solutions
Table 47. Revenue (Million US$) in Hemophilia Therapeutics Business of Biogen Idec, Inc. (2015-2020)
Table 48. Biogen Idec, Inc. Recent Developments
Table 49. Genetics Institute Basic Information List
Table 50. Genetics Institute Description and Business Overview
Table 51. Genetics Institute Hemophilia Therapeutics Products, Services and Solutions
Table 52. Revenue (Million US$) in Hemophilia Therapeutics Business of Genetics Institute (2015-2020)
Table 53. Genetics Institute Recent Developments
Table 54. Alpha Therapeutics Corporation Basic Information List
Table 55. Alpha Therapeutics Corporation Description and Business Overview
Table 56. Alpha Therapeutics Corporation Hemophilia Therapeutics Products, Services and Solutions
Table 57. Revenue (Million US$) in Hemophilia Therapeutics Business of Alpha Therapeutics Corporation (2015-2020)
Table 58. Alpha Therapeutics Corporation Recent Developments
Table 59. Expression Therapeutics Basic Information List
Table 60. Expression Therapeutics Description and Business Overview
Table 61. Expression Therapeutics Hemophilia Therapeutics Products, Services and Solutions
Table 62. Revenue (Million US$) in Hemophilia Therapeutics Business of Expression Therapeutics (2015-2020)
Table 63. Expression Therapeutics Recent Developments
Table 64. Swedish Orphan Biovitrum AB. Basic Information List
Table 65. Swedish Orphan Biovitrum AB. Description and Business Overview
Table 66. Swedish Orphan Biovitrum AB. Hemophilia Therapeutics Products, Services and Solutions
Table 67. Revenue (Million US$) in Hemophilia Therapeutics Business of Swedish Orphan Biovitrum AB. (2015-2020)
Table 68. Swedish Orphan Biovitrum AB. Recent Developments
Table 69. North America Hemophilia Therapeutics Market Size by Country (2015-2020) & (US$ Million)
Table 70. North America Hemophilia Therapeutics Market Size Share by Country (2015-2020)
Table 71. Europe Hemophilia Therapeutics Market Size by Country (2015-2020) & (US$ Million)
Table 72. Europe Hemophilia Therapeutics Market Size Share by Country (2015-2020)
Table 73. Asia-Pacific Hemophilia Therapeutics Market Size by Country (2015-2020) & (US$ Million)
Table 74. Asia-Pacific Hemophilia Therapeutics Market Size Share by Country (2015-2020) (US$ Million)
Table 75. Latin America Hemophilia Therapeutics Market Size by Country (2015-2020) & (US$ Million)
Table 76. Latin America Hemophilia Therapeutics Market Size Share by Country (2015-2020) (US$ Million)
Table 77. Middle East & Africa Hemophilia Therapeutics Market Size by Players (2015-2020) (US$ Million)
Table 78. Middle East & Africa Hemophilia Therapeutics Market Size Share by Players (2015-2020) (US$ Million)
Table 79. Hemophilia Therapeutics Market Trends
Table 80. Hemophilia Therapeutics Market Drivers
Table 81. Hemophilia Therapeutics Market Challenges
Table 82. Hemophilia Therapeutics Market Restriants
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hemophilia Therapeutics Market Size Year-over-Year 2015-2026 & (US$ Million)
Figure 2. Global Hemophilia Therapeutics Market Size (US$ Million), 2015 VS 2020VS 2026
Figure 3. Global Hemophilia Therapeutics Market Share by Regions: 2020 VS 2026
Figure 4. North America Hemophilia Therapeutics Market Size (US$ Million) Growth Rate (2015-2026)
Figure 5. Europe Hemophilia Therapeutics Market Size (US$ Million) and Growth Rate (2015-2026)
Figure 6. Asia-Pacific Hemophilia Therapeutics Market Size (US$ Million) and Growth Rate (2015-2026)
Figure 7. Latin America Hemophilia Therapeutics Market Size (US$ Million) and Growth Rate (2015-2026)
Figure 8. Middle East & Africa Hemophilia Therapeutics Market Size (US$ Million) and Growth Rate (2015-2026)
Figure 9. Global Hemophilia Therapeutics Market Share by Type in 2020 & 2026
Figure 10. hemophilia A Market Size (US$ Million) YoY Growth (2015-2026)
Figure 11. hemophilia B Market Size (US$ Million) YoY Growth (2015-2026)
Figure 12. hemophilia C Market Size (US$ Million) YoY Growth (2015-2026)
Figure 13. Global Hemophilia Therapeutics Market Size Share by Application in 2020 & 2026
Figure 14. Hospitals Market Size (US$ Million) YoY Growth (2015-2026)
Figure 15. Clinics Market Size (US$ Million) YoY Growth (2015-2026)
Figure 16. AmbulatorySurgicalCenters Market Size (US$ Million) YoY Growth (2015-2026)
Figure 17. Hemophilia Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 18. Global Top 5 and Top 10 Players Hemophilia Therapeutics Market Share in 2019
Figure 19. United States Hemophilia Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Canada Hemophilia Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Germany Hemophilia Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. France Hemophilia Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. U.K. Hemophilia Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Italy Hemophilia Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Russia Hemophilia Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Nordic Hemophilia Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Rest of Europe Hemophilia Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. China Hemophilia Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Japan Hemophilia Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. South Korea Hemophilia Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Southeast Asia Hemophilia Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. India Hemophilia Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Australia Hemophilia Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Rest of Asia-Pacific Hemophilia Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Mexico Hemophilia Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Brazil Hemophilia Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Rest of Latin America Hemophilia Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Turkey Hemophilia Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Saudi Arabia Hemophilia Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. UAE Hemophilia Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Rest of Middle East & Africa Hemophilia Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Bottom-up and Top-down Approaches for This Report
Figure 43. Data Triangulation
Keyplayers in Global Hemophilia Therapeutics Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application
Bayer AGPfizer, Inc.
Novo Nordisk A/S
Baxter International Inc.
Biogen Idec, Inc.
Genetics Institute
Alpha Therapeutics Corporation
Expression Therapeutics
Swedish Orphan Biovitrum AB.